Correlation Engine 2.0
Clear Search sequence regions


  • dyslipidemia (1)
  • humans (1)
  • lipid (6)
  • lipoprotein (1)
  • research (1)
  • SDC1 (1)
  • VEGF (8)
  • VEGF C (1)
  • Sizes of these terms reflect their relevance to your search.

    The vascular endothelial growth factor (VEGF) family plays a major role in tumors and ophthalmic diseases. However, increasingly more data reported its potential in regulating lipids. With its biological functions mainly expressed in lymphatic vessels, some factors in the families, like VEGF-A and VEGF-C, have been proved to regulate intestinal absorption of lipids by affecting chylous ducts. Other effects, including regulating lipoprotein lipase (LPL), endothelial lipase (EL), and recombinant syndecan 1 (SDC1), have also been confirmed. However, given the scant-related studies, further research should be conducted to examine the concrete mechanisms and provide pragmatic ways to apply them in the clinic. The VEGF family may treat dyslipidemia in specific ways that are different from common methods and concurrently contribute to the treatment of other metabolic diseases, like diabetes and obesity. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

    Citation

    Yan Zhou, Xueping Zhu, Huan Wang, Chenglin Duan, Hanming Cui, Jingjing Shi, Shuai Shi, Guozhen Yuan, Yuanhui Hu. The Role of VEGF Family in Lipid Metabolism. Current pharmaceutical biotechnology. 2023;24(2):253-265

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 35524661

    View Full Text